معرفی
Matthew Page is an Associate Professor and NHMRC Emerging Leadership Investigator Fellow at Monash University's School of Public Health and Preventive Medicine, leading research on methods for evidence synthesis. He holds roles such as Deputy Head of the Methods in Evidence Synthesis Unit and co-chair of the PRISMA Executive. His work focuses on improving systematic review quality, including co-developing the PRISMA 2020 statement and the RoB 2 tool for assessing bias in clinical trials. Page has led numerous studies addressing transparency, reproducibility, and bias in health research. He has held editorial roles at journals like the Cochrane Database of Systematic Reviews and the Journal of Clinical Epidemiology. His research spans interventions for musculoskeletal conditions, ADHD, and postpartum hemorrhage, with over 179 peer-reviewed publications. Awards include the Cochrane Bill Silverman Prize and multiple early-career recognitions.
Education: PhD in epidemiology (2011-2015), visiting postdoctoral fellow at University of Bristol (2015-2017).
Research Interests: Systematic review methodology, risk of bias assessment, reporting guidelines (PRISMA), health economics, and improving research transparency. His work bridges methodological innovation with applied clinical research, influencing global standards for evidence synthesis.
Awards: NHMRC Fellowships, Cochrane Bill Silverman Prize (2018), Australasian Epidemiological Association awards (2011-2013).
Grants & Projects: Leads projects on enhancing systematic review quality, updating PRISMA guidelines, and improving reporting/peer review practices. Active in initiatives like the PRISMA Executive and Cochrane Methods Group.
Labs/Teams: Methods in Evidence Synthesis Unit at Monash University, collaborating internationally on guideline development and bias assessment frameworks.
